1. Home
  2. BEAT vs CULP Comparison

BEAT vs CULP Comparison

Compare BEAT & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • CULP
  • Stock Information
  • Founded
  • BEAT 2015
  • CULP 1972
  • Country
  • BEAT United States
  • CULP United States
  • Employees
  • BEAT N/A
  • CULP N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • CULP Textiles
  • Sector
  • BEAT Technology
  • CULP Consumer Discretionary
  • Exchange
  • BEAT Nasdaq
  • CULP Nasdaq
  • Market Cap
  • BEAT 58.0M
  • CULP 54.5M
  • IPO Year
  • BEAT 2021
  • CULP N/A
  • Fundamental
  • Price
  • BEAT $1.79
  • CULP $4.29
  • Analyst Decision
  • BEAT Buy
  • CULP
  • Analyst Count
  • BEAT 1
  • CULP 0
  • Target Price
  • BEAT $8.00
  • CULP N/A
  • AVG Volume (30 Days)
  • BEAT 99.2K
  • CULP 28.6K
  • Earning Date
  • BEAT 11-06-2025
  • CULP 09-10-2025
  • Dividend Yield
  • BEAT N/A
  • CULP N/A
  • EPS Growth
  • BEAT N/A
  • CULP N/A
  • EPS
  • BEAT N/A
  • CULP N/A
  • Revenue
  • BEAT N/A
  • CULP $207,391,000.00
  • Revenue This Year
  • BEAT N/A
  • CULP $2.41
  • Revenue Next Year
  • BEAT $19.35
  • CULP $3.46
  • P/E Ratio
  • BEAT N/A
  • CULP N/A
  • Revenue Growth
  • BEAT N/A
  • CULP N/A
  • 52 Week Low
  • BEAT $0.91
  • CULP $3.42
  • 52 Week High
  • BEAT $3.48
  • CULP $6.20
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 60.65
  • CULP 48.60
  • Support Level
  • BEAT $1.74
  • CULP $4.25
  • Resistance Level
  • BEAT $2.03
  • CULP $4.42
  • Average True Range (ATR)
  • BEAT 0.11
  • CULP 0.15
  • MACD
  • BEAT 0.00
  • CULP -0.01
  • Stochastic Oscillator
  • BEAT 40.00
  • CULP 20.69

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: